Waitlist sharing · no medical claims

Share Mivara as a waitlist, not a treatment promise.

Use this page when someone asks what Mivara is. The share language is built for launch updates only while legal, clinical, pharmacy, privacy, payment, and advertising approvals are completed.

Share guardrails

Keep every message waitlist-only

approved
1
Rule 1

Use named warm recipients, owned profiles, inbound conversations, or manually vetted partner contacts only.

2
Rule 2

No scraped lists, purchased lists, uploaded custom audiences, cold bulk email, boosted posts, paid ads, or lead-form ads.

3
Rule 3

No PHI, medical history, medication questions, insurance IDs, photos, payment data, prescriptions, labs, diagnosis, or urgent advice.

4
Rule 4

Every public post or outbound message must keep the offer as waitlist-only launch updates.

Compliance preview: Mivara is configured for waitlist and operational readiness only. No prescriptions, diagnoses, medical advice, or paid treatment are available until legal, clinical, pharmacy, payment, and privacy approvals are complete.

Source-tagged waitlist links

Use the closest link for the channel so demand can be attributed without collecting sensitive details.

Founding access landing page

ready after deploy

Consumer demand capture from owned profiles and direct shares.

No payment, medical intake, prescriptions, outcomes, or private health details.

https://joinmivara.com/founding-access?utm_source=owned_channel&utm_medium=share&utm_campaign=founding_access

Referral share page

ready after deploy

Warm contacts who ask what to share.

Share language remains waitlist-only and avoids drug names or weight-loss promises.

https://joinmivara.com/share?utm_source=referral&utm_medium=share_page&utm_campaign=founding_access

Partner pilot page

ready after deploy

Benefits brokers, clinics, employers, wellness operators, and local partner contacts.

No patient data, contracts, referrals, paid services, or clinical promises.

https://joinmivara.com/partners?utm_source=partner_network&utm_medium=direct&utm_campaign=partner_pilot_pipeline

Post-approval pricing preview

blocked until approval

High-intent leads asking what paid enrollment may cost later.

Do not collect payment or deposits until processor, counsel, vendor, and privacy gates clear.

https://joinmivara.com/pricing?utm_source=pricing_question&utm_medium=direct&utm_campaign=post_approval_membership

Copy-safe share language

These drafts avoid specific medication claims, outcome claims, and fake proof.

Friend referral

I joined Mivara’s waitlist for updates about a future licensed clinician-reviewed metabolic health access pathway. It’s waitlist-only right now and does not request medical details: https://joinmivara.com/founding-access?utm_source=referral&utm_medium=share&utm_campaign=founding_access

Partner referral

Mivara is collecting non-clinical partner interest for a future compliance-first metabolic health access platform. No patient data, contracts, or paid services requested yet: https://joinmivara.com/partners?utm_source=referral&utm_medium=share&utm_campaign=partner_pilot_pipeline

Email share

Thought this might be relevant: Mivara is opening waitlist-only updates for a future clinician-reviewed metabolic health access pathway after approvals. https://joinmivara.com/founding-access?utm_source=email_share&utm_medium=email&utm_campaign=founding_access

Do not cross these lines

These controls protect the brand, vendor approvals, future ad accounts, and payment review.

Use named warm recipients, owned profiles, inbound conversations, or manually vetted partner contacts only.

No scraped lists, purchased lists, uploaded custom audiences, cold bulk email, boosted posts, paid ads, or lead-form ads.

No PHI, medical history, medication questions, insurance IDs, photos, payment data, prescriptions, labs, diagnosis, or urgent advice.

Every public post or outbound message must keep the offer as waitlist-only launch updates.

Stop and re-review if a message mentions drug names, dosing, guaranteed outcomes, before/after results, same-day prescription access, or compounded-drug FDA approval.